B
Bull
Bull · 25%NIVF
$0.57
Scenario price
$1.330
-0.019 (-1.42%)At close
Loading chart…
- High
- 1.430
- Open
- 1.310
- VWAP
- 1.35
- Vol
- 63.10K
- Mkt Cap
- —
- Low
- 1.300
- Amount
- 85.40K
- EV/EBITDA, TTM
- -0.01
NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.
AI analysis of NewGenIvf Group Ltd (NIVF)
sellNIVF is not a good buy right now due to its significant price decline and poor financial performance. The current price is $0.42, with a year-to-date change of -98.25%, indicating severe underperformance. Additionally, the RSI is at 25.414, suggesting the stock is oversold but may not rebound soon given the negative trends in revenue and net income.
Valuation Metrics
The current forward P/E ratio for NewGenIvf Group Ltd (NIVF) is 0.03, compared to its 5-year average forward P/E of 0.07.
Alphio AI Price Scenarios for NIVF
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
8.508-17NewsfilterNewGenIVF Completes Convertible Note Exchange Agreement
- 8.507-30Newsfilter
NewGen's Investment in K25.ai Shows Significant Appreciation
8.507-27seekingalphaNewGen Acquires Additional 3% Stake in K25.ai, Raising Ownership to 13%
8.507-27GlobenewswireNewGenIVF Acquires Additional Stake in K25.ai
- 8.507-27Newsfilter
NewGenIVF Acquires Additional Stake in K25.ai
NIVF FAQ — answered by Alphio AI
NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia. It operates in the Healthcare sector.
NIVF is not a good buy right now due to its significant price decline and poor financial performance. The current price is $0.42, with a year-to-date change of -98.25%, indicating severe underperformance. Additionally, the RSI is at 25.414, suggesting the stock is oversold but may not rebound soon given the negative trends in revenue and net income.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.